| Financial Year |
March 31 2023 |
| Monetary Funds |
1,469,807,787.12 |
| Held-for-trading Financial Assets |
950,390,467.88 |
| Notes Receivable |
2,309,606.02 |
| Accounts Receivable |
436,754,760.83 |
| Advances to Suppliers |
12,519,318.82 |
| Other Receivables |
60,049,130.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
94,807,424.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,323,509.83 |
| Total Current Assets |
3,294,996,916.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
103,737,389.84 |
| Investment Properties |
139,067,043.20 |
| Fixed Assetes |
390,822,081.78 |
| Under-construction Projects |
211,432,719.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
404,227,934.61 |
| R&D expenses |
1,277,253.47 |
| Goodwill |
8,876,674.01 |
| Long-Term Deferred and Prepaid Expenses |
1,257,811.79 |
| Deferred Income Tax Assets |
70,296,369.30 |
| Other Non-Current Assets |
9,944,481.26 |
| Sub-Total of Non-Current Assets |
1,362,244,193.23 |
| Total Assets |
4,657,241,109.95 |
| Short-Term Loans |
540,366,833.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
47,051,527.91 |
| Accounts Received In Advance |
37,666.80 |
| Employee Compensation Payable |
18,751,933.75 |
| Taxes Payable |
45,283,479.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
593,759,770.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
947,649.71 |
| Other Current Liabilities |
380,313.86 |
| Sub-Total of Current Liabilities |
1,250,145,746.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,762,177.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,139,277.75 |
| Total Liabilities |
1,292,285,023.76 |
| Paid-In Capital(Or Share Stock) |
247,937,843.00 |
| Capital Surplus |
1,266,137,335.79 |
| Surplus Reserve |
125,819,278.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,632,066,671.80 |
| Minority Stockholder's Interest |
21,346,404.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,343,609,681.92 |
| Owner's Equity（Stockholder's Equity） |
3,364,956,086.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,657,241,109.95 |
